News
AGTC
--
0.00%
--
DJ Applied Genetic Tech Price Target Announced at $14.00/Share by Stifel
Dow Jones · 6d ago
DJ Applied Genetic Tech Initiated at Buy by Stifel
Dow Jones · 6d ago
AGTC to Present at Upcoming Investor Conferences
GAINESVILLE, Fla. and CAMBRIDGE, Mar 02, 2021 (GLOBE NEWSWIRE via COMTEX) -- GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) --...
GlobeNewswire · 6d ago
--Analyst Actions: Stifel Starts Applied Genetic Technologies at Buy With $14 Price Target
MT Newswires · 6d ago
Global Natural Asphalt Market 2020 Development Analysis, Strategic Outlook, Growth Rate and Forecast to 2025
Feb 28, 2021 (CDN Newswire via Comtex) -- Global Natural Asphalt Market 2020 by Manufacturers, Type and Application, Forecast to 2025 is the latest excellent...
CDN Newswire · 02/28 10:33
Natural Asphalt Market Trends 2021, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, and Global Industry Forecast To 2027.
Feb 22, 2021 (The Expresswire) -- Global "Natural Asphalt Market" (2021-2027) research provides an outline of the business with key insights, applications...
The Express Wire · 02/22 09:32
Applied Genetic Up 37.6% Since SmarTrend Uptrend Call (AGTC)
SmarTrend identified an Uptrend for Applied Genetic (NASDAQ:AGTC) on February 5th, 2021 at $5.11. In approximately 2 weeks, Applied Genetic has returned 37.57% as of today's recent price of $7.03.
Comtex SmarTrend(R) · 02/20 10:04
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17)
Benzinga · 02/18 13:14
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16)
Benzinga · 02/17 12:26
Stocks Making New 52-Week Highs/Lows For Tuesday, Feb. 16, 2021 (Via Benzinga Pro's Signals Tool)
52-Week Highs: HomeStreet (HMST) Applied Genetic (AGTC) BTRS (BTRS) Utz Brands (UTZ) Aviat Networks (AVNW) Golden Entertainment (GDEN) Krystal Biotech (KRYS) So-Young (SY) Corning (GLW) Lightbridge
Benzinga · 02/16 19:50
SOS, WPG, CAN and BLUE among midday movers
Gainers: Luokung Technology (LKCO) +112%.Kubient (KBNT) +63%.SOS (SOS) +58%.Torchlight Energy Resources (TRCH) +54%.Protective Insurance (PTVCB) +53%.500.com (WBAI) +45%.ALJ Regional (ALJJ) +45%.Urban Tea (MYT) +44%.Canaan (CAN) +36%.Applied Genetic Techno...
Seekingalpha · 02/16 17:37
AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatme...
GlobeNewswire · 02/16 17:00
AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021
-AGTC executives will address critical success factors in gene therapy manufacturing and the value of the patient perspective in gene therapy development ---- GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technol...
GlobeNewswire · 02/16 13:00
INO, QS, RIOT and FSR among premarket gainers
Artelo Biosciences (ARTL) +63%.China Liberal Education Holdings Limited (CLEU) +59%.Helius Medical Technologies (HSDT) +29%.Denison Mines Corp. (DNN) +26% on $25M bought deal offering.Xeris Pharmaceuticals (XERS) +25% as EC OK's its Ogluo for
Seekingalpha · 02/12 13:25
10-Q: APPLIED GENETIC TECHNOLOGIES CORP
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 02/11 21:18
DJ Applied Genetic Technologies Corporation CEO Sue Washer on Q2 2021 Results -- Earnings Call Transcript >AGTC
Dow Jones · 02/11 20:11
Applied Genetic Technologies (AGTC) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Applied Genetic Technologies (AGTC) today and set a price target of $24.00. The
SmarterAnalyst · 02/11 17:25
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11)
Benzinga · 02/11 12:26
Applied Genetic Tech On Track to Provide Multiple Data Readouts for XLRP and ACHM Clinical Programs in 2021 and 2022 >AGTC
Applied Genetic Tech On Track to Provide Multiple Data Readouts for XLRP and ACHM Clinical Programs in 2021 and 2022 >AGTC
Dow Jones · 02/11 12:06
Applied Genetic Tech: Proceeds of $69.2M From a Recent Public Offering Provide Cash Runway Into Calendar Yr 2023 >AGTC
Applied Genetic Tech: Proceeds of $69.2M From a Recent Public Offering Provide Cash Runway Into Calendar Yr 2023 >AGTC
Dow Jones · 02/11 12:06
Webull provides a variety of real-time AGTC stock news. You can receive the latest news about AGTC through multiple platforms. This information may help you make smarter investment decisions.
About AGTC
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).